概括
口服避孕药 (OCs) 显著降低子宫内膜癌的风险. 长期使用提供了相当大的保护,在停止使用后,风险会恢复到基线. 配方类型也会影响保护作用.
科学领域:
- 妇科瘤学 妇科瘤学
- 生殖健康 生殖健康
- 癌症流行病学 癌症流行病学
背景情况:
- 子宫内膜癌是一种显著的妇科恶性瘤.
- 口服避孕药 (OCs) 广泛用于计划生育和激素调节.
研究的目的:
- 调查组合产品口服避孕药使用与子宫内膜癌风险之间的关联.
- 评估OCs的持续时间,最新性和配方对子宫内膜癌风险的影响.
主要方法:
- 一项病例对照研究,将79名患有子宫内膜癌的患者与203名对照患者进行比较.
- 对口服避孕药使用模式的回顾性分析,包括持续时间,近期和配方类型.
主要成果:
- 总体而言,6.3%的子宫内膜癌患者和15.3%的对照人使用了组合产品OCs.
- 与非使用者相比,OC使用者患子宫内膜癌的风险不足一半.
- 长期使用 (≥5年) 将风险降低三分之二;在停止使用后,保护性降低.
结论:
- 组合产品口服避孕药显示对子宫内膜癌有保护作用.
- 孕激素占主导地位的配方似乎比雌激素占主导地位的配方提供了更大的保护.
- 这些发现支持生物学上可信的机制,用于OC介导的子宫内膜癌的风险降低.
关键词:
年龄因素 年龄因素美国的美洲.癌症 癌症 癌症 癌症案例研究 案例研究避孕药是一种避孕药,用于避孕.避孕方法 避孕方法避孕方法 - - 副作用控制小组 控制小组 控制小组发达国家 发达国家糖尿病是一种糖尿病.疾病 疾病 疾病宫内膜癌 宫内膜癌是什么?民族团体 民族团体计划生育 计划生育方式在高血压的高血压.新生体 新生体 新生体北美北美北美北美北美北美北美北美北卡罗来纳州的北卡罗来纳州.北美北美北美北美北美北美北美北美北美北美北美肥胖问题 肥胖问题口服避孕药,联合避孕药口服避孕药 - 副作用的平价性.研究方法研究方法研究方法学研究研究研究研究研究研究.美国的美国.更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
相关概念视频
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
